Cargando…
Roadmap to personalized medicine
ABSTRACT: Standard clinical protocols and the concept “one drug fits all” that are currently used to treat illness in many cases are not effective, and strikingly so in the treatment of cancer, where 75% of therapeutic schemes are ineffective. The concept of personalized medicine is that the treatme...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Medical Schools
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428814/ https://www.ncbi.nlm.nih.gov/pubmed/22911518 http://dx.doi.org/10.3325/cmj.2012.53.294 |
_version_ | 1782241739613929472 |
---|---|
author | Qattan, Malak Demonacos, Constantinos Krstic-Demonacos, Marija |
author_facet | Qattan, Malak Demonacos, Constantinos Krstic-Demonacos, Marija |
author_sort | Qattan, Malak |
collection | PubMed |
description | ABSTRACT: Standard clinical protocols and the concept “one drug fits all” that are currently used to treat illness in many cases are not effective, and strikingly so in the treatment of cancer, where 75% of therapeutic schemes are ineffective. The concept of personalized medicine is that the treatment of the disease is designed on the basis of the individual needs of each patient and the factors that influence their response to different drugs. Individualization of patient care has the potential to generate novel effective therapies, limit the adverse drug effects, create optimal treatments for individual patients, and decrease the cost associated with chronic illness and complications of drug usage. However, to achieve the goals of personalized medicine many challenges must be addressed. Here we discuss possible ways to increase the consistency of data generated by basic research and their suitability for application in medicine. New technologies employing systems biology and computer based approaches will facilitate overcoming many of the scientific challenges in the field. Changes in the education of researchers, health professionals, and the public are also required to successfully implement personalized medicine as a routine in the clinic. Finally, shift of the focus away from the development of blockbuster drugs in the biopharmaceutical industry, and modifications in the legal system to accommodate novel advancements need to be considered. The joint effort of all interested parties is needed to generate an efficient roadmap that will take us rapidly and safely to effective individual treatment, which will eliminate diseases and create better health care for all. |
format | Online Article Text |
id | pubmed-3428814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Croatian Medical Schools |
record_format | MEDLINE/PubMed |
spelling | pubmed-34288142012-08-30 Roadmap to personalized medicine Qattan, Malak Demonacos, Constantinos Krstic-Demonacos, Marija Croat Med J Personalized Medicine Opinion Paper ABSTRACT: Standard clinical protocols and the concept “one drug fits all” that are currently used to treat illness in many cases are not effective, and strikingly so in the treatment of cancer, where 75% of therapeutic schemes are ineffective. The concept of personalized medicine is that the treatment of the disease is designed on the basis of the individual needs of each patient and the factors that influence their response to different drugs. Individualization of patient care has the potential to generate novel effective therapies, limit the adverse drug effects, create optimal treatments for individual patients, and decrease the cost associated with chronic illness and complications of drug usage. However, to achieve the goals of personalized medicine many challenges must be addressed. Here we discuss possible ways to increase the consistency of data generated by basic research and their suitability for application in medicine. New technologies employing systems biology and computer based approaches will facilitate overcoming many of the scientific challenges in the field. Changes in the education of researchers, health professionals, and the public are also required to successfully implement personalized medicine as a routine in the clinic. Finally, shift of the focus away from the development of blockbuster drugs in the biopharmaceutical industry, and modifications in the legal system to accommodate novel advancements need to be considered. The joint effort of all interested parties is needed to generate an efficient roadmap that will take us rapidly and safely to effective individual treatment, which will eliminate diseases and create better health care for all. Croatian Medical Schools 2012-08 /pmc/articles/PMC3428814/ /pubmed/22911518 http://dx.doi.org/10.3325/cmj.2012.53.294 Text en Copyright © 2012 by the Croatian Medical Journal. All rights reserved. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Personalized Medicine Opinion Paper Qattan, Malak Demonacos, Constantinos Krstic-Demonacos, Marija Roadmap to personalized medicine |
title | Roadmap to personalized medicine |
title_full | Roadmap to personalized medicine |
title_fullStr | Roadmap to personalized medicine |
title_full_unstemmed | Roadmap to personalized medicine |
title_short | Roadmap to personalized medicine |
title_sort | roadmap to personalized medicine |
topic | Personalized Medicine Opinion Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428814/ https://www.ncbi.nlm.nih.gov/pubmed/22911518 http://dx.doi.org/10.3325/cmj.2012.53.294 |
work_keys_str_mv | AT qattanmalak roadmaptopersonalizedmedicine AT demonacosconstantinos roadmaptopersonalizedmedicine AT krsticdemonacosmarija roadmaptopersonalizedmedicine |